Zeolite Chaga
Natural health product licensed in Canada
- Other names
- ZeoDetox Chaga
- Licence holder
- Mineral Medix Corp.
- NPN or DIN-HM
- 80097831
- Status
- Active licence
- Licence date
- 25 March 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to support detoxification. Source of fungal polysaccharides with immunomodulating properties.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. If you are taking any medication or have a medical condition, consult a health care practitioner prior to use. Individuals with kidney disease should not take this product except on the advice of a doctor. This product is not intended for the treatment of heavy metal poisoning. If exposure to heavy metals is known or suspected, call 911 or call your local Poison Control Center.
- Contre-indications
Do not use if you have gastric or duodenum ulcer. Do not use if you have allergy or sensitivity to mushrooms. Do not use if you are pregnant or breastfeeding.
- Effets indésirables connus
Hypersensitivity/allergy can occur in those sensitive to mushrooms or molds; avoid in people with a known allergy or sensitivity to chaga, its constituents, or any member of the hymenochaetaceae family; in which case, discontinue use. Some persons with excess energy may have an inability to sleep; therefore, do not take at bedtime. Gastrointestinal discomfort (e.g. flatulence) has been known to occur, in which case, reduce dose.
Source
Official Health Canada record, licence 80097831
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.